Repros Therapeutics (RPRX) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $57.16 -0.82%
Financial Fact:
General and administrative: 997K
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
General and administrative: 997K
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q3 EPS of ($0.27), $0.02 better than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Onto Innovation gains on bullish RBC initiation citing advanced packaging growth
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
